A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis-Reference-Cited by-同舟云学术

A multicenter, retrospective, observational study of the clinical outcomes and risk factors for relapse of ulcerative colitis at 1 year after leukocytapheresis

Published:2017-06-08 Issue:3 Volume:53 Page:387-396
ISSN:0944-1174
Container-title:Journal of Gastroenterology
language:en
Short-container-title:J Gastroenterol

Author:

Kobayashi Taku,Matsuoka Katsuyoshi,Yokoyama Yoko,Nakamura Takashi,Ino Tomoko,Numata Toyoko,Shibata Hiroshi,Aoki Hirofumi,Matsuno Yoshihiro,Hibi Toshifumi

Funder

Asahi Kasei Medical Co. Ltd.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00535-017-1356-8/fulltext.html

Reference24 articles.

1. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002;15:79–94.

2. Schroeder KW, Tremaine WJ, Iistrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med. 1987;317:1625–9.

3. Meyers S, Sachar DB, Goldberg JD, et al. Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology. 1983;85:351–7.